Ciprofloxacin: study card

Ciprofloxacin — Fluoroquinolone antibacterial. Study the mechanism, listed uses and warnings from the US label on one sourced card.

Generic name
Ciprofloxacin
Class
Fluoroquinolone antibacterial
Mechanism
Inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, disrupting processes required for bacterial DNA replication and maintenance.
Used for
UTIs due to specified susceptible bacteria in adults, and selected complicated UTI/pyelonephritis in children aged 1–17; acute uncomplicated cystitis use is reserved for patients without alternatives; Specified susceptible lower-respiratory infections in adults; acute chronic-bronchitis exacerbation use is reserved for patients without alternatives; Specified susceptible skin, bone and joint infections in adults; Post-exposure inhalational anthrax and source-specified plague treatment/prevention in adults and children
Common side effects
Nausea; Diarrhea; Abnormal liver function tests; Vomiting; Rash
Boxed warning
Fluoroquinolones can cause disabling, potentially irreversible tendon injury, peripheral neuropathy and CNS effects, sometimes together. They can worsen myasthenia gravis. The label calls for immediate discontinuation for these serious reactions and reserves selected uncomplicated infections for patients without alternative treatments.
Warnings
QT prolongation; Hepatotoxicity; C. difficile-associated diarrhea
Interactions
Tizanidine (contraindicated); Theophylline; Other CYP1A2 substrates

Brand questions use only name pairings verified against the linked product source. Unverified pairings are withheld from these questions; the other study content remains available.

Drug class families: Fluoroquinolone antibacterials

Read the source label ↗

Label date: 20260831 · For learning, not clinical decisions. US label and brand information; always consult the current source.

Source snapshot checked: 2026-10-21. The source document and selected fields were compared. The complete card has not had an independent clinical review.

Pronunciation

Ciprofloxacin: sip-roe-FLOX-a-sin

Pronunciation is shown for the US English generic name.

Other drugs in the same class

Fluoroquinolone antibacterials: Ofloxacin (ophthalmic), Levofloxacin, Moxifloxacin (ophthalmic), Ciprofloxacin (ophthalmic), Ciprofloxacin / Dexamethasone, Ofloxacin (otic)

Body system

Infectious disease · 21 Drug cards

Compare with related cards

Levofloxacin

Same class family: Fluoroquinolone antibacterials

Mechanism: Fluoroquinolone antibacterial active against designated susceptible bacteria.

On both cards: Common side effects — Nausea; Diarrhea · Warnings — QT prolongation; Hepatotoxicity; C. difficile-associated diarrhea

Only on the Levofloxacin card: Used for — Adult nosocomial or community-acquired pneumonia caused by the specified susceptible organisms; Adult complicated UTI; uncomplicated UTI only when no alternative treatment options exist; Adult acute bacterial sinusitis only when no alternative treatment options exist; Post-exposure inhalational anthrax and treatment/prophylaxis of plague in adults and children aged 6 months or older; pediatric formulation/weight restrictions apply · Common side effects — Headache; Insomnia; Dizziness · Interactions — Antacids / multivalent cations; Warfarin; Antidiabetic agents

Ofloxacin (ophthalmic)

Same class family: Fluoroquinolone antibacterials

Mechanism: Quinolone antimicrobial active against susceptible gram-positive and gram-negative bacteria causing eye infections.

Only on the Ofloxacin (ophthalmic) card: Used for — Bacterial conjunctivitis caused by listed susceptible organisms; safety and effectiveness below age 1 are not established; Bacterial corneal ulcers caused by listed susceptible organisms; safety and effectiveness below age 1 are not established · Common side effects — Transient ocular burning / discomfort; Stinging; Redness; Itching; Photophobia · Warnings — Hypersensitivity to quinolones (contraindicated) · Interactions — Theophylline (systemic quinolones); Caffeine (systemic quinolones); Warfarin (systemic quinolones)

Moxifloxacin (ophthalmic)

Same class family: Fluoroquinolone antibacterials

Mechanism: Topical fluoroquinolone anti-infective active against susceptible conjunctival pathogens.

Only on the Moxifloxacin (ophthalmic) card: Used for — Bacterial conjunctivitis caused by the listed susceptible organisms · Common side effects — Conjunctivitis; Decreased visual acuity; Dry eye; Ocular discomfort / pain; Ocular hyperemia · Warnings — Stop use for an allergic reaction; serious anaphylaxis has been reported with systemic quinolones, including moxifloxacin; Prolonged use may cause overgrowth of non-susceptible organisms; Avoid contact lenses when signs or symptoms of bacterial conjunctivitis are present

An item counts as shared only when both cards use the same wording. If a card does not list an item, that is not a statement that the effect never occurs.

Boxed warnings on related cards

Levofloxacin: Disabling and potentially irreversible tendon injury, peripheral neuropathy and CNS effects can occur together; discontinue immediately and avoid fluoroquinolones after these reactions. Avoid in known myasthenia gravis. Reserve uncomplicated UTI, acute bacterial sinusitis and acute bacterial exacerbation of chronic bronchitis for patients without alternative treatment options.